Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,135.20
-17.60 (-0.82%)
At close: Feb 1, 2026
Lupin Market Cap
Lupin has a market cap or net worth of 977.29 billion as of January 30, 2026. Its market cap has decreased by -2.21% in one year.
Market Cap
977.29B
Enterprise Value
977.60B
Revenue
247.51B
Ranking
n/a
PE Ratio
22.60
Stock Price
2,135.20
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 977.29B, an increase of 97,811.74%. That is a compound annual growth rate of 29.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 982.60B | 1.85% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.61T |
| Cipla | 1.07T |
| Zydus Lifesciences | 890.82B |
| Mankind Pharma | 876.80B |
| Aurobindo Pharma | 701.43B |
| Alkem Laboratories | 678.83B |
| Glenmark Pharmaceuticals | 568.89B |
| Laurus Labs | 520.96B |